[go: up one dir, main page]

NO920503D0 - Potensiering av antireaktiv-antiastmatisk effekt av inhalerte loekke diuretika ved inhalerte ikke-stereoidiske anti-inflammatoriske medikamenter - Google Patents

Potensiering av antireaktiv-antiastmatisk effekt av inhalerte loekke diuretika ved inhalerte ikke-stereoidiske anti-inflammatoriske medikamenter

Info

Publication number
NO920503D0
NO920503D0 NO920503A NO920503A NO920503D0 NO 920503 D0 NO920503 D0 NO 920503D0 NO 920503 A NO920503 A NO 920503A NO 920503 A NO920503 A NO 920503A NO 920503 D0 NO920503 D0 NO 920503D0
Authority
NO
Norway
Prior art keywords
inhaled
stereoidic
antiastmatic
antireactive
potentization
Prior art date
Application number
NO920503A
Other languages
English (en)
Other versions
NO920503L (no
Inventor
Sebastiano Bianco
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO920503D0 publication Critical patent/NO920503D0/no
Publication of NO920503L publication Critical patent/NO920503L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/618Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO92920503A 1991-02-09 1992-02-07 Potensiering av antireaktiv-antiastmatisk effekt av inhalerte loekke diuretika ved inhalerte ikke-stereoidiske anti-inflammatoriske medikamenter NO920503L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91101817 1991-02-09

Publications (2)

Publication Number Publication Date
NO920503D0 true NO920503D0 (no) 1992-02-07
NO920503L NO920503L (no) 1992-08-10

Family

ID=8206392

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920503A NO920503L (no) 1991-02-09 1992-02-07 Potensiering av antireaktiv-antiastmatisk effekt av inhalerte loekke diuretika ved inhalerte ikke-stereoidiske anti-inflammatoriske medikamenter

Country Status (15)

Country Link
US (2) US5366967A (no)
EP (1) EP0499142A3 (no)
JP (1) JPH0680587A (no)
KR (1) KR920016093A (no)
AU (1) AU652798B2 (no)
BR (1) BR9200430A (no)
CA (1) CA2060954A1 (no)
CS (1) CS35392A3 (no)
HU (1) HU209609B (no)
IE (1) IE920426A1 (no)
IL (1) IL100897A0 (no)
MX (1) MX9200570A (no)
NO (1) NO920503L (no)
NZ (1) NZ241541A (no)
ZA (1) ZA92891B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0499143B1 (en) * 1991-02-09 1999-05-06 B.S.D. BIO SCIENCE DEVELOPMENT SNC Di OMINI C. & ZUCCARI G. Anti-reactive anti-asthmatic activity of acetylsalicylic acid by inhalation
DE69634865D1 (de) 1995-04-14 2005-07-21 Smithkline Beecham Corp Dosierinhalator für Salmeterol
DE69637257T2 (de) 1995-04-14 2008-06-12 Smithkline Beecham Corp. Verfahren zur Herstellung eines Dosierinhalators
WO1996032151A1 (en) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Metered dose inhaler for fluticasone propionate
PL180880B1 (pl) 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
DE10034802A1 (de) * 2000-07-18 2002-01-31 Bayer Ag Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
WO2002092946A1 (en) * 2001-05-11 2002-11-21 Ray Robert Shorey Temporary rooftop and stairway safety rail system
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) * 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
JP2016518388A (ja) 2013-04-30 2016-06-23 オティトピック インク. 乾燥粉末配合および使用方法
CA2977083A1 (en) 2014-02-20 2015-08-27 Kambiz Yadidi Dry powder formulations for inhalation
US10758537B2 (en) * 2015-09-30 2020-09-01 Rutgers, The State University Of New Jersey Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888343A (en) * 1986-09-15 1989-12-19 Bristol-Myers Company Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process
JPH0720862B2 (ja) * 1989-01-27 1995-03-08 ヘキスト・アクチエンゲゼルシヤフト 吸入用喘息治療剤
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
DE4010536A1 (de) * 1990-04-02 1991-10-10 Boehringer Mannheim Gmbh Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure

Also Published As

Publication number Publication date
NO920503L (no) 1992-08-10
US5366967A (en) 1994-11-22
HU209609B (en) 1994-09-28
HU9200390D0 (en) 1992-04-28
AU1077092A (en) 1992-08-13
NZ241541A (en) 1996-05-28
IL100897A0 (en) 1992-11-15
JPH0680587A (ja) 1994-03-22
BR9200430A (pt) 1992-10-13
MX9200570A (es) 1994-07-29
CS35392A3 (en) 1992-08-12
KR920016093A (ko) 1992-09-24
US5750559A (en) 1998-05-12
CA2060954A1 (en) 1992-08-10
EP0499142A3 (en) 1993-05-05
EP0499142A2 (en) 1992-08-19
ZA92891B (en) 1992-12-30
HUT60438A (en) 1992-09-28
AU652798B2 (en) 1994-09-08
IE920426A1 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
NO920503D0 (no) Potensiering av antireaktiv-antiastmatisk effekt av inhalerte loekke diuretika ved inhalerte ikke-stereoidiske anti-inflammatoriske medikamenter
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
FI951245A7 (fi) Liuosten muodostaminen
NO923526L (no) Fremgangsmaate for fremstilling av nafta
FI935803A0 (fi) Nedbrytning av organiska foereningar
NO953244D0 (no) Derivater av cyklodepeptid PF 1022
NO921777L (no) Fremgangsmaate for fremstilling av isoparaffiner
FI933502L (fi) Oxidation av titantetraklorid
FI935135A0 (fi) Foerfarande foer rening av TiO2-malm
DE69321109D1 (de) Herstellung von trifluorvinylethern
KR950701894A (ko) 하이드로 플루오로 알칸 제조 방법(production of hydrofluoroalkanes)
NO940190D0 (no) Anvendelse av x-ketoglutarat
NO952949D0 (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
DE69304766D1 (de) Herstellung von Rohrverbindungen
NO931399D0 (no) Anvendelse av naturstein
ITMI920605A1 (it) Associazioni di composti ad attivita' antivirale
NO923728D0 (no) Regioselektiv syntese av 1,5-diarylpyrazol-antiinflammatoriske midler
FI951212A0 (fi) beta-metyylikarbapeneemivälituotteiden valmistus
NO951808D0 (no) Fremgangsmåte ved fremstilling av enatiomert rene triazolylbenzotriazoler
NO930459D0 (no) Fremgangsmaate for fremstilling av plateformede konstruksjonselemente
NO173109C (no) Forskaling for bruk ved fremstilling av langsgaaende konstruksjoner
SE9201829D0 (sv) "atracta-sign" framstaellning av skyltstommar
FIU920385U0 (fi) Kombination av stordiaprojektor och projektorplatta
FI428U1 (fi) Verktyg foer formning av haestsko
SE9303498D0 (sv) Brandförvaring av gasol-tuber-flaskor "BRANDTUVEN"